Pressure BioSciences, Inc. (PBIO)

OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
-95.65%
Market Cap 21.48K
Revenue (ttm) 1.50M
Net Income (ttm) -33.25M
Shares Out 42.97M
EPS (ttm) -0.89
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 800
Average Volume 9,163
Open 0.0398
Previous Close 0.0005
Day's Range 0.0005 - 0.0398
52-Week Range 0.0001 - 0.2000
Beta -0.09
RSI 47.46
Earnings Date Mar 27, 2026

About Pressure BioSciences

Pressure BioSciences, Inc. develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide. The company’s products/services are based on Ultra Shear Technology platform, which turns hydrophobic oil-based supplements, therapeutics, and other active ingredients to water-soluble, bioavailable, oil-in-water nano emulsion formulations; BaroFold Technology platform, that is used to improve the quality and lower the production costs of protein biotherapeutics; and Pressure Cycli... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1978
Employees 16
Stock Exchange OTCMKTS
Ticker Symbol PBIO
Full Company Profile

Financial Performance

In 2023, Pressure BioSciences's revenue was $1.98 million, an increase of 14.36% compared to the previous year's $1.73 million. Losses were -$35.20 million, 97.7% more than in 2022.

Financial Statements

News

There is no news available yet.